|
Search
Collections
Benchmarks
Upload document
Indication
Rare Disorder
Rename entity
Add alias
Merge entity
Delete entity
Embed entity
1 clinical trial
2 drugs
Clinical trial
DART: Dual Anti-CTLA-4 and Anti-PD-1 Blockade in Rare Tumors
Status: Active (not recruiting)
, Estimated PCD: 2026-05-01
Drug
Lurbinectedin
Drug
T-VEC